Shank proteins are abundant scaffold proteins in the postsynaptic density (PSD) region of brain synapses. Mutations in Shank proteins are associated with autism, schizophrenia, and Alzheimer's disease. To gain insights into Shank protein interactions at the PSD, we determined the solution structures of the src homology 3 (SH3) domains of all three mammalian Shank proteins. Our findings indicate that they have identical and typical SH3 folding motifs, but unusual target-binding pockets. An investigation into the interaction between the Shank SH3 domains and the proline-rich region of the Cav1.3 calcium channel revealed an atypical interaction in which the highly acidic specificity binding pocket of the SH3 domains binds to a Cav1.3 region containing a cluster of three Arg residues. Our study provides insights into Shank SH3-mediated interactions.
The Shank proteins, also known as ProSAP's, are found in high abundance in the postsynaptic density (PSD) region of excitatory synapses in the brain [1] . Three Shank proteins (Shank1, Shank2, and Shank3) have been identified in mammals. In addition, the three Shank proteins can be expressed as various isoforms due to alternative promoters and splicing. The longest isoforms include multiple protein-protein interaction modules, such as ankyrin-repeat domains, a src-homology 3 (SH3) domain, a PSD-95/discs large/ZO-1 (PDZ) domain, a long proline-rich region, and a sterile alpha motif (SAM). The Shank proteins are thought to act like a 'master scaffold' that organizes neurotransmitter receptors, cytoskeletal proteins, other scaffold proteins, ion-channels, signaling molecules, and enzymes to form a large signal processing device in synaptic PSD regions [2, 3] . Shank proteins play a crucial role in synaptic plasticity, and they are thought to be essential for learning and the formation of memories in the brain [4] . In recent years, characteristic mutations that occur in Shank proteins have been linked to neurodevelopmental or neuropsychiatric disorders [5] such as autism spectrum disorder (ASD) [6] [7] [8] [9] [10] , intellectual disability [11] , and schizophrenia [7, 12] . Moreover, Shank proteins have also been implicated in Alzheimer's disease [13] . Although the best characterized paralog is Shank3 [14] [15] [16] , mutations in the Shank1 and Shank2 genes have also been reported to be associated with ASD [17, 18] . For example, the overexpression of Shank3
Abbreviations ASD, autism spectrum disorder; AZ, active zone; PSD, postsynaptic density; SAM, sterile alpha motif; SH3, src-homology 3. can cause manic-like behavior in mice, suggesting that abnormalities in the copy number of Shank proteins can also induce certain psychiatric disorders [19] . However, it remains to be determined how these mutations and copy number variations affect the integrity of the PSD and in turn cause neurological abnormalities.
The human genome contains about 300 SH3 domains. SH3 domains are approximately 60 residues long and are predominantly found as an independently folded unit in many signal transduction proteins [20] . A typical SH3 domain provides an interface for target proteins through binding to proline-rich sequences normally containing a core PxxP motif (where 'x' indicates any amino acid). The majority of these interactions are further classified into either class I (RxLPPxP) or class II motifs (xPPLPxR) that bind in opposite directions (as reviewed in [21, 22] ). The SH3 domains from the three human Shank proteins share 60-70% sequence identity ( Fig. 1) . Amino acid sequence alignments suggest that the SH3 domains of the Shank proteins should have a distinct composition of amino acids in their potential target binding pockets, which should preclude them from binding to typical proline-rich targets. To date, only few target proteins have been reported that can potentially interact with Shank proteins via the SH3 domain, which include Densin-180 [23] and the voltage-dependent calcium channel 1.3 (Cav1.3) [24] . In addition, the SH3 domain could also interact with the ankyrin-repeat domain of Shank itself [25] , which might potentially contribute to the formation of higher order structures of Shank proteins [26] . The deletion of the ankyrin repeat and SH3 domains from Shank3 leads to a reduced size of the dendritic spine [27] . Some of the mutations found in patients with psychiatric disorders are also located within the SH3 domain [3, [28] [29] [30] . However, the specific recognition motif for the three Shank SH3 domains has not yet been identified.
Here, we have determined the NMR solution structures of the SH3 domains from all three mammalian Shank proteins. All three structures have a typical SH3 fold and are very similar to one another. As predicted, a comparison of their target binding pockets to those of other well-known SH3 domains revealed that the Shank SH3 domains have lost several conserved residues that are commonly involved in the interaction with PxxP motifs. It has been reported that Shank1 and Shank3 can interact with the Cav1.3 channel and that they can cluster it to the PSD [24] . The binding between Shank and Cav1.3 has been shown to arise from a two-point interaction which involves both the SH3 and the PDZ domains [24] . Although it is clear that the PDZ domain from Shank interacts with the class I PDZ binding motif that is located at the C-terminal end of Cav1.3 [24, 31] , the specific binding site for the SH3 domain remains to be determined and hence we have also investigated the interactions of the Shank SH3 domains with the C-terminal proline-rich region of Cav1.3. Fig. 1 . Amino acid sequence alignment of human Shank SH3 domains with the SH3 domains from human RIM-binding protein 2 (O15034), cacophony RIM-binding protein (A0A0B4JDC9), yeast Nbp2 (Q12163), mouse c-Crk (Q64010), yeast Myosin-5 (Q04439), and human Abl (P00519). The residue numbers and the secondary structures for the SH3 domain of SNK3 are also displayed. Unusual amino acids predicted to be found in the potential PxxP target-binding pockets of the Shank SH3 domains are highlighted in yellow. The three acidic residues located in the specificity pockets of the SH3 domains of Shank and human RIM-binding protein in common are highlighted in purple. The red arrow denotes the position of the conserved Trp residue found in canonical SH3 domains.
Materials and methods

Protein expression and purification
Three genes encoding the SH3 domains of the Shank proteins including SNK1-SH3 (residues 554-613 of human Shank1A), SNK2-SH3 (residues 527-586 of rat Shank2E), and SNK3-SH3 (residues 471-530 of human Shank3A) were chemically synthesized with codons optimized for expression in Escherichia coli (Thermo Fisher Scientific, Waltham, MA, USA). To facilitate direct comparisons, in this manuscript, for SNK2-SH3 we have adopted the residue numbering of human Shank2. The genes were subcloned into either the pE-SUMO vector with a SUMO proteinase site (LifeSensors, Inc., Malvern, PA, USA) or into the pET15 vector (Invitrogen, Carlsbad, CA, USA) with a TEV proteinase site, using the NdeI and XhoI sites. For SNK2-SH3, the Cterminal Cys585 residue was mutated to Ser in order to prevent undesired disulfide formation during the sample preparation. Two mutant Cys-SNK2-SH3 and Cys-SNK3-SH3 proteins in which an extra cysteine residue was added to the N-terminal end of the protein were generated using QuickChange mutagenesis. All proteins were overexpressed in Escherichia coli strain BL21 (DE3) by addition of 0.5-1.0 mM IPTG. Uniformly 15 N-and 13 C, 15 N-labeled SH3 domains were produced in the cytoplasm of bacteria grown in minimal M9 media containing 0.5 gÁL À1 15 NH 4 Cl and 3 gÁL À1 13 C 6 -glucose (or unlabeled glucose). The SUMO fusion and the His-tagged proteins were both purified using chelating Sepharose fast flow resin (GE Healthcare, Chicago, IL, USA) charged with Ni 2+ to allow for immobilized metal affinity chromatography. The SUMO fusion proteins were then excised by SUMO proteinase I (LifesSensors, Inc., Malvern, PA, USA), while the His-tagged proteins were digested with TEV protease. TEV protease was expressed and purified from the pRK793 plasmid as previously described [32] . The cleaved SUMO and His-tag were removed by passing through the Ni-column once again. The purified SH3 domains were exchanged into the desired buffer and concentrated using a centrifugal filter unit (MilliporeSigma, Burlington, MA, USA). Protein purification (>95%) was verified using SDS/PAGE and Coomassie brilliant blue staining.
NMR measurements
All NMR samples of the SH3 domains contained 0. All NMR experiments required for the structure determination were performed at 25°C on Bruker Avance 500 or 700 MHz NMR spectrometers equipped with triple resonance inverse cryoprobes with a single axis z-gradient. Main-chain assignments of the SH3 domains were completed using two-dimensional 1 N heteronuclear NOE data were obtained using a 5-sec train of 120°proton pulses. To investigate the interactions between the SH3 domains and the C-terminal prolinerich region of Cav1.3, five peptides corresponding to all the PxxP motifs that are present in this region which include, pxxp1 (Ac-HVQRPSIPPASDTEK-NH 2 ), pxxp2 (Ac-SDT EKPLFPPAGNSV-NH 2 ), pxxp3 (Ac-RRRLLPPTPPSH RR-NH 2 ), pxxp4 (Ac-QDDVLPSPALPHRAA-NH 2 ), and pxxp5 (Ac-RSWATPPATPPYRD-NH 2 ), were purchased as synthetic peptides with more than 95% purity from Genscript (San Diego, CA, USA). For the sake of comparison, the following PxxP peptides were also studied: Ac-RR RLLP-NH 2 (the N-terminal portion of pxxp3), Ac-PPT PPSHRR-NH 2 (the C-terminal portion of pxxp3), Ac-GRRLLPPTPPSHRR-NH 2 (pxxp3 with a R1G mutation), Ac-GRRQLPQTPSTPRP-NH 2 (from Cav2.1), Ac-PRRSV PPSPTSPRA-NH 2 (from the proline-rich region of Shank1), and Ac-PIEEFTPTPAFPAL-NH 2 (from the PDZ domain of Shank1). These peptides were titrated into NMR samples containing 15 N-labeled SH3 domains up to a 1 : 5 or 1 : 8 protein-peptide ratio. All the peptide concentrations were determined using the molar extinction coefficients at 214 nm [34] . Chemical shift perturbations (CSP) were monitored by recording 1 N resonances, using the equa-
. All spectra were processed using NMRPipe/NMRDraw [35] and analyzed using the NMRVIEW software [36] .
Structure calculation
CYANA version 2.0 [37] was used to calculate the structures of the SNK1-SH3, SNK2-SH3, and SNK3-SH3 protein domains. This was done using distance restraints generated from the automated NOE assignment protocol implemented in CYANA. The dihedral angle restraints were predicted by TALOS, and hydrogen bond restraints for the b-sheet were based on the direct observation in NMR experiments (see above). Finally, the 25 lowest energy structures from a total of 200 were selected and used for the analysis. All molecular graphics used in this manuscript were created using MOLMOL [38] .
The atomic coordinates and resonance assignments have been deposited in the protein data bank (SNK1-SH3: 6CPI, SNK2-SH3: 6CPJ, SNK3-SH3: 6CPK) and the BMRB database (SNK1-SH3: BMRB-30436, SNK2-SH3: BMRB-30437, SNK3-SH3: BMRB-30438).
Surface plasmon resonance
The interactions between SNK2-SH3 or SNK3-SH3 and the synthetic peptides corresponding to the PxxP motifs present in Cav1.3 (see above) were evaluated by SPR using a BIAcore X100 instrument (GE Healthcare). Cys-SNK2-SH3 and Cys-SNK3-SH3 were immobilized onto a CM5 sensor chip (GE Healthcare) using thiol coupling. The running buffer contained 20 mM Tris-HCl pH 7.5, 100 mM KCl, and 0.01% (v/v) Tween-20. Different concentrations of the peptide sample were injected at a flow rate of 30 lLÁmin À1 with a contact time of 1 min at 25°C. The chip was regenerated by injecting 1M NaCl. The BIAEVALUA-TION software 2.0 (GE Healthcare) was used to process the SPR sensorgrams and for curve fitting to obtain the dissociation constants (K d 's). Two different concentrations in each experiment were injected twice to obtain the fitting errors (SEM).
Results and Discussion
All backbone amide resonances as well as the amide and imino side-chain resonances of the Asn, Gln, and Trp residues were unambiguously assigned in the 1 H, 15 N-HSQC NMR spectra of all three SH3 domains (Fig. S1 ). The structures of the SH3 domains were then determined using proton-proton distance information derived from NOESY experiments using the automated NOE assignment protocol implemented in the CYANA software. All the parameters from the structure calculations are summarized in Table S1 . Figure 2A shows the superimposed 25 lowest energy NMR structures and the ribbon representations for the three SH3 domains. As expected from the relatively high sequence identity (Fig. 1) , all three structures are almost identical to one another. All structures have a typical SH3 fold, which contains a small b-barrel consisting of five antiparallel b-strands connected by three loops (RT loop, n-Src-loop and distal-loop from the N-terminus) and a small 3 10 helix [22] . The backbone rmsd is 0.53 A when they are overlaid using the backbone heavy atoms in folded regions (residues 559-609 of SNK1-SH3, residues 530-582 of SNK2-SH3, and residues 476-527 of SNK3-SH3) (Fig. 2B) . The pairwise rmsd's of all the combinations including SNK1-SH3/SNK2-SH3, SNK1-SH3/ SNK3-SH3, and SNK2-SH3/SNK3-SH3 are 0.94 A, 0.89 A, and 0.95 A, respectively. During the preparation of this manuscript, a crystal structure for SNK3-SH3 was reported [39] , which is essentially identical to our solution structure for SNK3-SH3 except for the conformation of parts of the RT, n-Src, and distal loops as well as both terminals (Fig. S2) . Our heteronuclear NOE data shows that all these regions are very flexible in solution (Fig. S2B) . All the structural discrepancies therefore can be attributed to the flexibility of these loop regions in solution and the absence of crystal contacts. The backbone rmsd between the crystal and solution structures is 0. 6 A when these flexible regions are excluded. As mentioned above, the Shank SH3 domains have a noncanonical amino acid arrangement in their potential target-binding pockets. The most remarkable feature is the absence of a conserved Trp residue (located at the beginning of the third b-strand at position 508 of SNK3-SH3) (Fig. 1) . This Trp residue is highly conserved among canonical SH3 domains and forms a hydrogen bond to the backbone of typical PxxP targets [40] . The orientation of the indole ring of this Trp is an important determinant for the binding mode for PxxP motifs [41] (Fig. 1) . In all three Shank SH3 domains this Trp is replaced with a Phe residue, which cannot provide a hydrogen bond. There are two additional unusual residues around the potential target binding groove of Shank SH3 domains, including the lysine and cysteine residues at positions 480 and 524 of SNK3-SH3 (Fig. 1) . A tyrosine residue is often found at position 524 in many regular SH3 domains [40] , which can also provide a hydrogen bond to the backbone of PxxP targets [42, 43] .
In an attempt to define the recognition sequences for the unique SH3 domains of the Shank proteins, we have investigated the interaction between the SH3 domains and the proline-rich region of Cav1.3 (from residue 1688 to the C-terminal end; Fig. S3 ). It has been reported that the SH3 domain contributes to the interaction between Shank and Cav1.3 by binding to the proline-rich region of Cav1.3 as well as to the PDZ domain binding through the C-terminal end [24] . Our original attempts to express the entire proline-rich region of Cav1.3 or some of its larger fragments using various prevalent protein-fusion expression systems were not successful most likely due to the unstructured and/or insoluble nature of this region. Therefore, we decided to focus on the five PxxP motifs that can be identified in this region (Table 1, Fig. S3 ). First, we have utilized SPR to examine the binding of synthetic peptides encompassing these regions to the SNK2-SH3 and SNK3-SH3 protein domains that were immobilized onto the SPR chip. Figure 3 shows all the SPR responses obtained for the five PxxP peptides from Cav1.3, and it is clear that only one peptide, namely, pxxp3, could bind to SNK3-SH3. The K d value derived from the affinity fitting is 3.5 AE 0.3 9 10 À4 M which represents a relatively weak interaction. Almost identical results were obtained for SNK2-SH3 with a K d value of 3.1 AE 0.4 9 10 À4 M (Fig. S4) . Given that the interaction with Cav1.3 occurs synergistically with the PDZ domain this could be a sufficient contribution for higher affinity [24] . NMR titration experiments confirmed that all three SH3 domains could bind to the pxxp3 peptide (Fig. 4) , while all other peptides failed to bind, consistent with the SPR results (data not shown). All the CSPs were observed to be in fast exchange on the NMR time scale and were rather small in magnitude, which is expected from the K d value. The residues with relatively larger CSPs were then mapped onto the structures (Fig. 4C) . It seems that all three Shank SH3 domains present a similar interface for binding the pxxp3 peptide. Although the pxxp3 peptide can be classified as a class I SH3 binding motif (RxLPPxP), our CSP data indicate that the pxxp3 peptide does not bind to Shank SH3 domains in a canonical manner. The typical SH3 target binding involves three binding pockets which include two xP-dipeptide binding pockets (located at the top and bottom of the 3 10 -helix), and a specificity pocket (located between the RT and n-Src loops) [44] . The residues which experience CSP are mapped mostly onto the specificity pockets (Fig. 4C) , suggesting that the pxxp3 peptide does not occupy the xP di-peptide binding pockets. Indeed, the residues on the specificity binding pockets are strictly conserved in all three Shank SH3 domains compared to other region of the protein (Fig. 4D) , supporting our observations. Hence, the pxxp3 peptide would be classified as a nonconsensus ligand for Shank SH3 domains [45] , which is probably responsible for the relatively weak interactions observed.
It should be noted that the pxxp3 motif is absent in the related Cav1.2 channel, which is in line with the differences reported for Shank interactions with Cav1.3 and Cav1.2 [24] . On the other hand, Cav2.1 and Cav2.2 channels contain a similar motif to pxxp3 (Table 1) . However, both SPR and NMR data confirmed that the Cav2.1 peptide cannot bind to Shank-SH3 domains (Figs 3 and S5) . We propose that the cluster of three Arg residues that is present only in the pxxp3 motif may be essential for binding rather than the pxxp motif. In order to further test this notion, we have studied the pxxp3-R1G peptide in which the first Arg is replaced with a Gly similar to the Cav2.1 peptide ( Table 1) . As expected, this mutant peptide produced a K d of >10 À3 M which is substantially weaker than the wild-type (Fig. 3) . Consistently, the N-terminal portion of pxxp3 (pxxp3-nt, Table 1 ) did cause similar CSPs to the full-length peptide (Fig. 4B) . The Unusual amino acid residues found in the canonical target-binding pockets, including the specificity pocket and two xP pockets of Shank SH3 domains are also shown. The position of one of the genetic mutations found in SNK2 of ASD patients, S557 is indicated. (D) The positions of the sequence differences between three SH3 domains are mapped on the SNK1-SH3 structure. Nonconserved, weakly conserved, and conserved residues are highlighted in red, orange and yellow, respectively, gray parts are identical.
smaller CSPs were attributed to the weaker K d compared to the full-length peptide (Fig. S6) , suggesting that residues beyond the N-terminal portion also contribute to the interaction to some extent. However, a peptide encompassing this C-terminal portion of pxxp did not bind by itself according to our SPR measurements (data not shown).
Interestingly this PxxP region of Cav2.2 was previously shown to interact with the SH3 domain of CASK [46] , showing differentiation between SH3 domains of these two synaptic multidomain scaffolding proteins.
One of the genetic mutations found in AD patients, S557N, is located proximal to the specificity pocket of SNK2-SH3 (Fig. S7) [17] and we observed chemical shift changes for this residue upon binding of the pxxp3 peptide (Fig. 4) . However, the SNK2-SH3-S557N mutant protein showed only slightly weaker binding to the pxxp3 peptide (Fig. S8) . Although there is currently no in vivo evidence, S557 is predicted to be phosphorylated and therefore this mutation may have an impact on strengthening the binding to Cav1.3. Hence, we have also investigated the SNK2-SH3-S557D mutant; however, this extra phosphomimetic negative charge did not have any effect on the interaction with pxxp3 (Fig. S8) .
In order to study if the Shank-SH3 domain could form intramolecular or intermolecular crosslinks with Shank, we also studied the binding of two additional PxxP peptides which are present inside the Shank proteins (see Table 1 ); however, neither of these peptides did bind (Fig. S9) .
Since a subset of SH3 domains are known to bind to ubiquitin [47] [48] [49] , we also investigated whether the Shank-SH3 domain could bind to this protein. However, no chemical shift changes were detected when unlabeled ubiquitin was titrated into a sample of 15 N-labeled Shank SH3 domains (Fig. S10 ). This observation is consistent with the notion that ubiquitin normally binds to the PxxP binding interface of SH3 domains, and that Shank-SH3 has a modified recognition site.
The RIM-binding protein (RIM-BP) is one of the major components that forms the core of the active zone (AZ) at the presynaptic terminal [50] . RIM-BP contains three separate SH3 domains and it can interact simultaneously with the RIM protein, which is the central scaffold protein in the AZ, and with Ca 2+ -channels. In addition, the PDZ domain of RIM can also bind to the C-terminal PDZ binding motif of Ca 2+ -channels [51] , and this ternary complex is essential for the recruitment of Ca 2+ channels to the AZ. It has been demonstrated that the SH3 domain of RIM-BP can also bind to the pxxp3 peptide region of the Cav1.3 channel [52] . Figure 1 also shows the sequence alignment of the SH3 domains from Shank and RIMBPs. The most obvious similarity is that the SH3 domain of RIM-BP has also lost the conserved Trp residue and that it is replaced with Phe as well (Fig. 1) . It is noteworthy that both the Shank and RIM-BP SH3 domains have several acidic residues in common in their target binding pockets which include E487, E489, and E505 (Fig. 1) . Although the entire sequence identity is low, when the available 3D-structure of the SH3 domain (third domain) of human RIM-BP (PDB code: 2CSI) is superimposed onto the SNK3-SH3 structure, these acidic residues are positioned in a very similar manner in the specificity pocket (Fig. 5A ). According to these results, both SH3 domains possess a highly acidic specificity pocket for target recognition. As is obvious from the data presented in Table 1 , the most characteristic feature of the pxxp3 peptide that differentiates it from the other PxxP motifs in Cav1.3 is the presence of a cluster of three Arg residues. Most likely, the highly acidic specificity pockets of both SH3 domains are important for accommodating this positively charged portion of the pxxp3 motif of Cav1.3.
The SH3 domain of cacophony (cac) RIM-BP also interacts with the analogous PxxP motif of the cac Ca 2+ -channel (Table 1 ) [53] . This motif lacks one arginine and a hydrophobic Leu residue when compared to the 'RRRLLPPTP' region of pxxp3. The crystal structure of the complex revealed that the cac PxxP peptide interacts with the second SH3 domain of cac RIM-BP in a typical type I target interaction (PDB code: 4Z89). This interaction has been reported to have a K d of 20 lM which is 10-fold stronger than the K d we have observed here for Shank SH3 and the pxxp3 peptide. Figure 5B shows the overlay of SNK3-SH3 and the complex structure of cac RIM-BP with the bound cac PxxP peptide. As discussed above, our NMR CSP data do not agree with the interface that is seen in this complex structure especially around the xP binding pockets. The unusual residues located in the xP binding pockets of Shank SH3 domains particularly the lysine residue at position 480 in SNK3-SH3 might be responsible for the absence of interaction with these pockets (Fig. 5B) . Therefore, we have tested this by producing a K480Y mutant of SNK3-SH3 using SPR, however, it had an almost identical K d to the wild-type protein (Fig. S11) . On the other hand the loss of the conserved Trp residue does not seem to be a major factor, as the SH3 domain of cac RIM-BP also has a Phe residue instead of Trp.
It is noteworthy that the pxxp3 motif is located about 250 amino acids upstream from the C-terminal PDZ binding motif of Cav1.3 (Fig. S3) . A disordered structure prediction with the web-server DISOPRED3 predicts some structure in this region of Cav1.3 and therefore these binding sites might be closely located due to tertiary folding. Otherwise, this interaction would introduce some structural changes in this region, which perhaps have an effect on the regulation of the channel. Unfortunately, we were unable to investigate the entire proline-rich region of Cav1.3 to rule out the possibility that the Shank SH3 domains may bind to a non-PxxP motif. Such noncanonical interactions have been reported for some specific SH3 domains [44] . Nevertheless, to the best of our knowledge, this work represents the first report that identifies a motif that can interact with the Shank SH3 domains. Together with the solution structures of all three shank SH3 domains determined in this study, our findings should help to identify additional binding motifs in other Shank-binding proteins, which would lead in turn to a better understanding of the molecular networks that are created in the PSD.
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